6
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Clinical and angiographic results of coronary artery stenting using PURA-VARIO (PUVA) stents

, , , , , , & show all
Pages 156-160 | Published online: 10 Jul 2009

Refernces

  • Fischman DL, Leon MB, Bairn DS et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331: 496–501.
  • Schatz RA, Bairn DS, Leon M et al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation 1991; 83: 148–61.
  • Serruys PW, de Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331: 489–95.
  • Sigwart U, Puel J, Mirkovitch V, Joffre E, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987; 316: 701–706.
  • Pepine CJ, Holmes DRJ. Coronary artery stents. American College of Cardiology. J Am Coll Cardiol 1996; 28: 782–94.
  • Grewe PH, Machraoui A, Deneke T, Barmeyer J, Muller KM. Structural analysis of 16 different coronary stent systems. Z Kardiol 1997; 86: 990–99.
  • Oesterle SN, Whitbourn R, Fitzgerald PJ et al. The stent decade: 1987 to 1997. Stanford Stent Summit faculty. Am Heart J 1998; 136: 578–99.
  • Machraoui A, Lange S, von Dryander S et al. Praktikabili-taet eines doppelblind randomisierten Studiendesigns zum angiographischen Vergleich von drei slotted tube stents (PUNIPAST-Studie). Z Kardiol 1999; 88 Suppl 1: 101.
  • Reimers B, Moussa I, Kobayashi N. Immediate results with the newly designed PURA-VARIO coronary stent. Am J Cardiol 1997; 80 suppl 7A: 38S.
  • Serruys PW, Foley DP, de Feyter PJ, Quantitative Coronary Angiography In Clinical Practice. Dordrecht, Kluwer Academics, 1994.
  • Lee HS, Densem C, Levy RD, Bennett DH, Ray SG, Brooks NH. Impact of stenting on coronary angioplasty procedures. Heart 1998; 80: 505–508.
  • Schomig A, Neumann FJ, Walter H et al. Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy. J Am Coll Cardiol 1997; 29: 28–34.
  • Ellis SG, Savage M, Fischman D et al. Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. Initial results of a multicenter experience. Circulation 1992; 86: 1836–44.
  • Carver AL, Dawkins KD, Gray HH, Haywood GA, Morgan JM, Simpson IA. Intracoronary Multi-link stents: experience in 218 patients using aspirin alone. Heart 1998; 80: 499–504.
  • Ruygrok P, Barron G, Ormiston J et al. Introduction of the Multilink stent into routine angioplasty practice: early angiographic and clinical outcome. Cathet Cardiovasc Diagn 1998; 43: 147–52.
  • Dean LS, George CJ, Roubin GS et al. Bailout and corrective use of Gianturco-Roubin flex stents after percutaneous transluminal coronary angioplasty: operator reports and angiographic core laboratory verification from the National Heart, Lung, and Blood Institute/New Approaches to Coronary Intervention Registry. J Am Coll Cardiol 1997; 29: 934–40.
  • Dean LS, George CJ, Holmes DRJ et al. The use of the Gianturco-Roubin intracoronary stent: the New Approaches to Coronary Intervention (NACI) registry experience. Am J Cardiol 1997; 80: 89K–98K.
  • Anzuini A, Rosanio S, Legrand V et al. Wiktor stent for treatment of chronic total coronary artery occlusions: short- and long-term clinical and angiographic results from a large multicenter experience. J Am Coll Cardiol 1998; 31: 281–88.
  • Martinez EL, Lopez MJ, Alonso M. Wiktor coronary stent for elective placement with an antiaggregation regimen. WINE study. WINE Group Study. Rev Esp Cardiol 1998; 51: 450–57.
  • Oemrawsingh PV, Tuinenburg JC, Schalij MJ et al. Clinical and angiographic outcome of Micro Stent II implantation in native coronary arteries. Am J Cardiol 1998; 81: 152–57.
  • Webb JG Popma JJ Lansky AJ et al. Early and late assessment of the Micro Stent PL coronary stent for restenosis and suboptimal balloon angioplasty. Am Heart J 1997; 133: 369–74.
  • Zheng H, Corcos T, Favereau X et al. Preliminary experience with the NIR coronary stent. Cathet Cardiovasc Diagn 1998; 43: 153–58.
  • Wohrle J, Al-Khayer E, Grotzinger U et al. Comparison of the heparin coated vs the uncoated Jostent - no influence on restenosis or clinical outcome. Eur Heart J 2001; 22: 1808–16.
  • Colombo A, Di Mario C, Reimers B et al. Coronary stenting in 1000 consecutive patients. Long-term clinical and angiographic results. G Ital Cardiol 1997; 27: 19–31.
  • Kastrati A, Schuhlen H, Hausleiter J et al. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial. Circulation 1997; 96: 462–67.
  • Serruys PW, van Hout B, Bonnier H et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998; 352: 673–81.
  • Bauters C, Hubert E, Prat A et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 1998; 31: 1291–98.
  • Klues HG, Radke PW, Hoffmann R, von Dahl J. Pathophysiology and therapeutic concepts in coronary restenosis. Herz 1997; 22: 322–34.
  • Nageh T, de Belder AJ, Thomas MR, Williams IL, Wain-wright RJ. A randomised trial of endoluminal reconsctruc-tion comparing the NIR stent and Wallstent in angioplasty of long segment coronary disease: results of the RENEWAL study. Am Heart J 2001; 141: 971–76.
  • Miketic S, Carlsson J, Tebbe U. Randomized comparison of J&J Crown versus NIR stent after routine coronary angioplasty. Am Heart J 2001; 142: E8.
  • Bairn DS, Cutlip DE, Midei M et al. Final results of a randomized trial comparing the Multi-Link stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol 2001; 87: 157–62.
  • Regar E, Serruys PW, Bode C et al. Angiographic findings of the multicenter randomized study wirth the Sirolimus-eluting Bx Velocity balloon-expandable stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size. Circulation 2002; 106: 1949–56.
  • Grube E, Silber S, Hauptmann KE et al. TAXUS I: Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003; 107: 38–42.
  • Morice MC, Serruys PW, Sousa JE et al. A randomized comparison of a Sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773–80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.